Wexford Capital L.P., Insider at Arno Therapeutics, Inc (ARNI), sold 325 shares at $0.48 ($156) on 2013-10-04, disclosed to the SEC on 2013-10-09.
Open-market sale of $156 ARNI by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TUSK | BUY | 2019-11-15 | $49K | — | Filing → |
| TUSK | SELL | 2018-08-01 | $20.2M | — | Filing → |
| TUSK | SELL | 2018-07-03 | $105.1M | — | Filing → |